Betternostics SL, 31110 Noáin, Spain.
IMG Pharma Biotech, Research and Development Division, 48170 Zamudio, Spain.
Medicina (Kaunas). 2024 Jul 25;60(8):1204. doi: 10.3390/medicina60081204.
Recent advancements in mass spectrometry have significantly enhanced our understanding of complex lipid profiles, opening new avenues for oncological diagnostics. This review highlights the importance of lipidomics in the comprehension of certain metabolic pathways and its potential for the detection and characterization of various cancers, in particular melanoma. Through detailed case studies, we demonstrate how lipidomic analysis has led to significant breakthroughs in the identification and understanding of cancer types and its potential for detecting unique biomarkers that are instrumental in its diagnosis. Additionally, this review addresses the technical challenges and future perspectives of these methodologies, including their potential expansion and refinement for clinical applications. The discussion underscores the critical role of lipidomic profiling in advancing cancer diagnostics, proposing a new paradigm in how we approach this devastating disease, with particular emphasis on its application in comparative oncology.
近年来,质谱技术的进步极大地促进了我们对复杂脂质谱的理解,为肿瘤学诊断开辟了新的途径。本综述强调了脂质组学在理解某些代谢途径及其在检测和表征各种癌症(特别是黑色素瘤)中的应用的重要性。通过详细的案例研究,我们展示了脂质组学分析如何在识别和理解癌症类型方面取得重大突破,并发现有助于诊断的独特生物标志物。此外,本综述还讨论了这些方法的技术挑战和未来展望,包括它们在临床应用中的扩展和改进的潜力。讨论强调了脂质组学分析在推进癌症诊断方面的关键作用,提出了一种新的方法来研究这种毁灭性疾病,特别强调了它在比较肿瘤学中的应用。